BMC Infectious Diseases (Nov 2020)

Correction to: The use of intravenous immunoglobulin gamma for the treatment of severe coronavirus disease 2019: a randomized placebo-controlled double-blind clinical trial

  • Naser Gharebaghi,
  • Rahim Nejadrahim,
  • Seyed Jalil Mousavi,
  • Seyyed-Reza Sadat-Ebrahimi,
  • Reza Hajizadeh

DOI
https://doi.org/10.1186/s12879-020-05628-w
Journal volume & issue
Vol. 20, no. 1
pp. 1 – 2

Abstract

Read online

An amendment to this paper has been published and can be accessed via the original article.